Related references
Note: Only part of the references are listed.Benzothiazole head group based cationic lipids: Synthesis and application for gene delivery
Bhavani Kedika et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Amphiphilic Cationic Carbosilane-PEG Dendrimers: Synthesis and Applications in Gene Therapy
Javier Sanchez-Nieves et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes
Matthaeus Noga et al.
BIOMATERIALS (2013)
Gene therapy enters the pharma market: The short story of a long journey
Hildegard Buening
EMBO MOLECULAR MEDICINE (2013)
Nanoparticles as 'smart' pharmaceutical delivery
Chiranjib Chakraborty et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2013)
Inhaled proteins: Challenges and perspectives
Flore Depreter et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Gene therapy clinical trials worldwide to 2012 an update
Samantha L. Ginn et al.
JOURNAL OF GENE MEDICINE (2013)
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Huub Schellekens et al.
PHARMACEUTICAL RESEARCH (2013)
Advances and trends in the design, analysis, and characterization of polymer-protein conjugates for PEGylaided bioprocesses
Jose Gonzalez-Valdez et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA
Jagadish Beloor et al.
BIOMATERIALS (2012)
Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation
Eun Ju Lee et al.
BIOPROCESS AND BIOSYSTEMS ENGINEERING (2012)
Liposomal delivery of proteins and peptides
Janani Swaminathan et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Albumin-based nanoparticles as potential controlled release drug delivery systems
Ahmed O. Elzoghby et al.
JOURNAL OF CONTROLLED RELEASE (2012)
State of the art in PEGylation: The great versatility achieved after forty years of research
Gianfranco Pasut et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The Business of RNAi Therapeutics in 2012
Dirk Haussecker
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
Genc Basha et al.
MOLECULAR THERAPY (2011)
Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery
Alejandro Mendez-Ardoy et al.
NANOMEDICINE (2011)
State-of-the-art gene-based therapies: the road ahead
Mark A. Kay
NATURE REVIEWS GENETICS (2011)
A special report on India's biotech scenario: Advancement in biopharmaceutical and health care sectors
Chiranjib Chakraborty et al.
BIOTECHNOLOGY ADVANCES (2010)
PEGylation of therapeutic proteins
Simona Jevsevar et al.
BIOTECHNOLOGY JOURNAL (2010)
Update on gene therapy for immunodeficiencies
Donald B. Kohn
CLINICAL IMMUNOLOGY (2010)
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency
Francesca Ferrua et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Bone Marrow Transplantation and Alternatives for Adenosine Deaminase Deficiency
H. Bobby Gaspar
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2010)
Delivery of Therapeutic Proteins
Dipak S. Pisal et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Biopharmaceutical benchmarks 2010
Gary Walsh
NATURE BIOTECHNOLOGY (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Biological Gene Delivery Vehicles: Beyond Viral Vectors
Yiqi Seow et al.
MOLECULAR THERAPY (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A
Karthik Ramani et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Protein therapeutics: A summary and pharmacological classification
Benjamin Leader et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Gene therapy clinical trials worldwide to 2007 - an update
Michael L. Edelstein et al.
JOURNAL OF GENE MEDICINE (2007)
Hydrophobically modified hydroxyethyl starch:: Synthesis, characterization, and aqueous self-assembly into nano-sized polymeric micelles and vesicles
Ahmed Besheer et al.
BIOMACROMOLECULES (2007)
Standard mutation nomenclature in molecular diagnostics - Practical and educational challenges
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
FDA drug approval summary: Pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)
Patricia Anne Dinndorf et al.
ONCOLOGIST (2007)
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Si-Shen Feng
NANOMEDICINE (2006)
Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia
Iain C. Macdougall et al.
LANCET (2006)
Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids
G Gregoriadis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles:: In vitro and in vivo studies
G Kaul et al.
PHARMACEUTICAL RESEARCH (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
The design of cationic lipids for gene delivery
B Martin et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase
YL Lo et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Bionanotechnology based on silica nanoparticles
WH Tan et al.
MEDICINAL RESEARCH REVIEWS (2004)
The design and development of pegfilgrastim (PEG-rmetHuG-CSF, neulasta((R)))
G Molineux
CURRENT PHARMACEUTICAL DESIGN (2004)
Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery
GF Paciotti et al.
DRUG DELIVERY (2004)
Trends in development and approval times for new therapeutics in the United States
JM Reichert
NATURE REVIEWS DRUG DISCOVERY (2003)
Cationic lipid vectors for plasmid DNA delivery
A Hirko et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Efficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis:: In vitro and in vivo studies
L Vincent et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity
Y Yamamoto et al.
NATURE BIOTECHNOLOGY (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: Comparison with the corresponding antibody-enzyme conjugate
MJ Fonseca et al.
PHARMACEUTICAL RESEARCH (2003)
Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins
E Mastrobattista et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Treating cancer with PEG intron - Pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation
RM Bukowski et al.
CANCER (2002)
Biodegradable poly (ethylenimine) for plasmid DNA delivery
CH Ahn et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Biophysical aspects of using liposomes as delivery vehicles
AS Ulrich
BIOSCIENCE REPORTS (2002)
Adaptive immune responses of legumin nanoparticles
T Mirshahi et al.
JOURNAL OF DRUG TARGETING (2002)
Cell-specific delivery of genes with glycosylated carriers
M Hashida et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
KL Lindsay et al.
HEPATOLOGY (2001)
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes
N Maurer et al.
BIOPHYSICAL JOURNAL (2001)
Roles of lipid polymorphism in intracellular delivery
IM Hafez et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
SC Semple et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Antimetastatic effect of hepatotropic liposomal adriamycin on human metastatic liver tumors
I Matsuda et al.
SURGERY TODAY (2001)
A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro
C Kneuer et al.
BIOCONJUGATE CHEMISTRY (2000)
Current status of pH-sensitive liposomes in drug delivery
DC Drummond et al.
PROGRESS IN LIPID RESEARCH (2000)
Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA
C Kneuer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability
DD Stuart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2000)
Cationic microparticles: A potent delivery system for DNA vaccines
M Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1
DD Stuart et al.
CANCER GENE THERAPY (2000)
Analysis of the stability and degradation products of triptolide
YP Mao et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Share Paper
